Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00587483 · ClinicalTrials.gov registry record · NA
Amiodarone for the Prevention of Reperfusion Ventricular Fibrillation
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 342
- Enrollment target
NCT00587483: Completed NA study, sponsored by Mayo Clinic.
NCT00587483 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 342 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00587483, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 342 participants
- Enrollment target
Study Summary
This was a prospective, randomized, double blinded study in which patients undergoing a cardiopulmonary bypass (CPB) with aortic cross clamping were randomly assigned to receive amiodarone, lidocaine, or saline placebo prior to removal of the aortic cross clamp. (CPB is a technique that temporarily takes over the function of the heart and lungs during surgery, maintaining the circulation of blood and the oxygen content of the body.) Specifically, we will test the hypothesis that amiodarone is superior to both lidocaine and placebo in the prevention of a severely abnormal heart rhythm when the blood flow is restored to the heart after the aortic cross clamp is removed.
Interventions
- DRUG Placebo
- DRUG Lidocaine
- DRUG Amiodarone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 342 participants |
| Start Date | 2007-11 |
| Est. Completion | 2010-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00587483
The ClinicalTrials.gov registry entry for NCT00587483 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 342 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00587483 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00587483 about?
NCT00587483 is a clinical study titled "Amiodarone for the Prevention of Reperfusion Ventricular Fibrillation". This was a prospective, randomized, double blinded study in which patients undergoing a cardiopulmonary bypass (CPB) with aortic cross clamping were randomly assigned to receive amiodarone, lidocaine, or saline placebo prior to removal of the aortic cross clamp. (CPB is a technique that temporarily ...
What is the current status of trial NCT00587483?
This trial is currently completed. It is a NA study. The enrollment target is 342 participants. The study started on 2007-11. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00587483?
The interventions under investigation include: Placebo (DRUG), Lidocaine (DRUG), Amiodarone (DRUG).
Who is sponsoring clinical trial NCT00587483?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.